RE:Merck Deal / Haters BegoneI totally agree. That´s a very good result for the company - offside the food market. It´s been a long way for Enwave reaching that point with Merck...For me it´s one of the most important company goals, because this could be a door opener for other REV-technologie contracts in the biotech field (the potential market for Biopharmaceuticels is estimated at $ US 67 billion).
As determined Merck signed a 10 year non-exclusive Rev-license with an option to exclusively license for specific vaccines. The pps should be positively affected by that.